Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Latest filing published 23 Sept 2026 for Caris Life Sciences, Inc., €208k.
Filing timeline
BuySaleJohn Russel Denton
Insider track record
Disclosed buys
2
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+7.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
John Russel Denton: trading record in brief
All filings by John Russel Denton on record concern Caris Life Sciences, Inc. We count 6 filings; the first trade dates from 3 March 2025 and the latest from 22 September 2026.
Both buying and selling appear: 2 purchases worth €224k, against 1 sale worth €208k. Purchases outweigh sales by €16k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 share grants. Since January 2026: no purchases and 1 sale on the market.
On 23 September 2026 came the latest disclosure, an open-market sale for €208k in Caris Life Sciences, Inc. The last purchase on record was published on 10 November 2025, which is 348 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to John Russel Denton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
7,500 shares@ US$31.8168Common StockSEC:0002071923-26-000007:0
63,971 shares0Common StockSEC:0002071923-26-000002:0
4,184 shares@ US$24.092.0% of flowCommon StockSEC:0002071923-25-000009:0
Canonical exit: 5 Feb 2026 (T+90)
238,230 shares@ US$18.60100.0% of flowCommon StockSEC:0001104659-25-061810:0
4 of 4 declarations
